Concepedia

Author

Sarah C. Lappin

GlaxoSmithKline (United Kingdom)

Also Known As

Lappin, Sarah Crawford, S.C. Lappin, Sarah C. Lappin

8

Publications

541

Citations

6

H-Index

27

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)
SC

About

Sarah C. Lappin is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

435

2

Natural Sciences

2

2

314

3

Biochemistry

2

2

314

4

Health Sciences

1

1

37

5

Social Sciences

1

1

14

Sarah C. Lappin

×

6

Publications

538

Citations

6

H-Index

YearCitations

Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist

Martin J. Gunthorpe, Harshad K. Rami, Jeffrey C. Jerman,

Neuropharmacology

2003

272

Characterization of SB-705498, a Potent and Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of the Receptor

Martin J. Gunthorpe, Sara Luis Hannan, Darren Smart,

Journal of Pharmacology and Experimental Therapeutics

2007

103

TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation

Sarah C. Lappin, Andrew D. Randall, Martin J. Gunthorpe,

European Journal of Pharmacology

2006

70

Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1

Susan M. Westaway, Mervyn Thompson, Harshad K. Rami,

Bioorganic & Medicinal Chemistry Letters

2008

42

Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons

Sarah C. Lappin, Tim Dale, Jon T. Brown,

Brain Research

2005

37

Inhibition of Ih reduces epileptiform activity in rodent hippocampal slices

Catherine H. Gill, Jon T. Brown, Nadia Shivji,

Synapse

2006

14

Page 1